Lista de obras - Claudio Gasperini - Dominio Público Uruguay

'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence.

artículo científico publicado en 2003

A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis☆

scientific article published on 01 July 2000

A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions.

artículo científico publicado en 1999

A controlled study of potential risk factors preceding exacerbation in multiple sclerosis.

artículo científico publicado en 1995

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

article

A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis.

artículo científico publicado en 1998

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

artículo científico publicado en 1998

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

artículo científico publicado en 2011

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

article

Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.

artículo científico publicado en 2013

Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression

artículo científico publicado en 2020

Alexithymia in multiple sclerosis: relationship with fatigue and depression.

artículo científico publicado en 2007

Anatomical and functional correlates of cognitive deficit in multiple sclerosis.

artículo científico publicado en 1993

Assessing response to interferon-β in a multicenter dataset of patients with MS.

artículo científico publicado en 2016

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

article

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

artículo científico publicado en 2000

Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome

artículo científico publicado en 2013

CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes

artículo científico publicado en 2014

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

artículo científico publicado en 1998

Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients

artículo científico publicado en 1999

Deep grey matter volume loss drives disability worsening in multiple sclerosis.

artículo científico publicado en 2018

Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study

scientific article published on 10 December 2020

Detecting new lesion formation in multiple sclerosis: the relative contributions of monthly dual-echo and T1-weighted scans after triple-dose gadolinium.

artículo científico publicado en 1998

Differential diagnosis in multiple sclerosis.

artículo científico publicado en 2001

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis

artículo científico publicado en 2020

Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.

artículo científico

Early relapses after the first dose of natalizumab in active multiple sclerosis patients

artículo científico publicado en 2008

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

artículo científico publicado en 2013

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

artículo científico publicado en 2016

Efficacy and safety of laquinimod in multiple sclerosis: current status

artículo científico publicado en 2013

Emerging oral drugs for multiple sclerosis

artículo científico publicado en 2008

Emerging oral drugs for relapsing-remitting multiple sclerosis.

artículo científico

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

artículo científico publicado en 2015

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years ⬇️

artículo científico publicado el 15 de noviembre de 2003

From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study

artículo científico publicado en 2014

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

scientific article published on 01 October 1999

High-dose contrast-enhanced MRI in multiple sclerosis

scientific article published on 01 May 1996

Home based management in multiple sclerosis: results of a randomised controlled trial.

artículo científico publicado en 2002

Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support

artículo científico publicado en 2019

Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study

artículo científico publicado en 2011

Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis

artículo científico publicado en 2011

Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis

artículo científico publicado en 2013

Irreversible total blindness in multiple sclerosis

scientific article published on 01 June 1991

Lifespan normative data on rates of brain volume changes

scientific article published on 22 May 2019

Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis

artículo científico publicado en 2012

Longitudinal assessment of multiple sclerosis with the brain-age paradigm

scientific article published on 14 April 2020

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

artículo científico publicado en 2020

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

artículo científico publicado en 2016

Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1a.

artículo científico publicado en 1999

Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials.

artículo científico publicado en 1999

Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images

scientific article published on 01 October 1999

MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients

artículo científico publicado en 2014

Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis

artículo científico publicado en 2000

Natalizumab discontinuation and disease restart in pregnancy: a case series.

artículo científico publicado en 2015

Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.

artículo científico publicado en 2015

Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study

artículo científico publicado en 2009

Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis

artículo científico

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study

artículo científico publicado en 2017

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

artículo científico publicado en 1999

Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems

artículo científico publicado en 2016

Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire).

artículo científico publicado en 2013

Progression of regional grey matter atrophy in multiple sclerosis.

artículo científico publicado en 2018

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.

artículo científico publicado en 2015

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.

artículo científico publicado en 2011

Proteolytic balance in patients with multiple sclerosis during interferon treatment

artículo científico publicado en 2002

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

scientific article published on 01 March 1997

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis

scientific article published on 22 October 2019

Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study

artículo científico publicado en 2008

Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose

artículo científico publicado en 2000

Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis.

artículo científico publicado en 1998

Serum lactate as a novel potential biomarker in multiple sclerosis

artículo científico publicado en 2014

T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis

artículo científico publicado en 2015

T regulatory cells are markers of disease activity in multiple sclerosis patients

artículo científico publicado en 2011

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

artículo científico publicado en 2018

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

artículo científico publicado en 2018

The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis

scientific article published on 01 October 2005

The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis

artículo científico publicado en 2015

The prevalence of multiple sclerosis in central Italy.

artículo científico publicado en 2010

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

scientific article published on 06 August 2020

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study

scientific article published on 10 February 2014

Unilateral meningitis: unusual central nervous system involvement in rheumatoid arthritis

artículo científico publicado en 2020

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge

artículo científico publicado en 2018

Lista de obras de Claudio Gasperini

'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence.

A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis☆

A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions.

A controlled study of potential risk factors preceding exacerbation in multiple sclerosis.

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis.

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.

Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression

Alexithymia in multiple sclerosis: relationship with fatigue and depression.

Anatomical and functional correlates of cognitive deficit in multiple sclerosis.

Assessing response to interferon-β in a multicenter dataset of patients with MS.

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome

CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients

Deep grey matter volume loss drives disability worsening in multiple sclerosis.

Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study

Detecting new lesion formation in multiple sclerosis: the relative contributions of monthly dual-echo and T1-weighted scans after triple-dose gadolinium.

Differential diagnosis in multiple sclerosis.

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis

Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.

Early relapses after the first dose of natalizumab in active multiple sclerosis patients

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

Efficacy and safety of laquinimod in multiple sclerosis: current status

Emerging oral drugs for multiple sclerosis

Emerging oral drugs for relapsing-remitting multiple sclerosis.

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years ⬇️

From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

High-dose contrast-enhanced MRI in multiple sclerosis

Home based management in multiple sclerosis: results of a randomised controlled trial.

Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support

Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study

Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis

Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis

Irreversible total blindness in multiple sclerosis

Lifespan normative data on rates of brain volume changes

Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis

Longitudinal assessment of multiple sclerosis with the brain-age paradigm

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1a.

Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials.

Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images

MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients

Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis

Natalizumab discontinuation and disease restart in pregnancy: a case series.

Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.

Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study

Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems

Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire).

Progression of regional grey matter atrophy in multiple sclerosis.

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.

Proteolytic balance in patients with multiple sclerosis during interferon treatment

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis

Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study

Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose

Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis.

Serum lactate as a novel potential biomarker in multiple sclerosis

T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis

T regulatory cells are markers of disease activity in multiple sclerosis patients

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis

The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis

The prevalence of multiple sclerosis in central Italy.

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease